Priorities for Antiretroviral Therapy Research in Sub-Saharan Africa: A 2002 Consensus Conference in Zambia
Thursday, 02 April 2009 05:59    PDF Print E-mail
Aconsensus conference was held to discuss priorities for antiretroviral therapy (ART) research in Zambia, one of the world’s most heavily HIV-afflicted nations. Zambia, like other resource- limited settings, has increasing access to highly active antiretroviral therapy (HAART) because of declining drug costs, use of government-purchased generic medications, and increased global donations. For sustained delivery of care with HAART in a resourceconstrained medical and public health context, operational research is required and clinical trials are desirable. The priority areas for research are most relevant today given the increasing availability of HAART.
Attachments:
FileDescriptionFile size
Download this file (Zulu - Priorities for Zambian HIV research (JAIDS 2004).pdf)Zulu - Priorities for Zambian HIV research (JAIDS 2004).pdf 66 Kb